Fuse Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fuse Medical generated cash of $443,786, which is more than the previous year. Cash used in financing activities reached the amount of -$353,473 last year. Net change in cash is therefore $90,313.
Cash Flow
| 2014 | -1.16M | -70.31K | 1.29M |
|---|---|---|---|
| 2015 | -375.14K | -7.00K | 322.75K |
| 2016 | -237.90K | 300 | 896.92K |
| 2017 | 1.60M | -11.60K | -1.56M |
| 2018 | 2.47M | -104.93K | -2.33M |
| 2019 | -4.73K | -15.31K | 275.05K |
| 2020 | 236.65K | -20.75K | -127.74K |
| 2021 | -1.77M | 0 | 1.14M |
| 2022 | 34.79K | 0 | -440.13K |
| 2023 | 443.78K | 0 | -353.47K |
FZMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 147.85K | 553.19K | 1.18M | 1.09M | 844.31K | 804.71K | 778.44K | 8.15K | 67.55K | 12.33K |
Operating activities | ||||||||||
Net income | 1.45M | 3.09M | -1.58M | -1.43M | -3.31M | 3.95M | 699.67K | -585.93K | -801.54K | -1.40M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 131.57K | 137.40K | 67.63K | 104.14K | 107.07K | 49.68K | 14.52K | 14.16K | 25.07K | 13.28K |
Stock-based compensation expense | 0 | 22.85K | 257.91K | 553.18K | 627.67K | 0 | 42.60K | 63K | 418K | 0 |
| Deferred income tax benefit | 0 | 22.85K | 257.91K | 553.18K | 627.67K | 0 | 42.60K | 63K | 418K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 603.19K | -1.88M | -64.07K | -1.98M | -1.62M | 917.68K | -62.09K | 239.94K | -116.92K | -54.33K |
Inventories | 227.58K | -1.47M | -1.16M | 1.60M | 1.12M | 1.88M | 2.02M | 55.88K | 50.17K | 111.73K |
Accounts payable | -3.39M | 1.23M | 1.22M | 483.73K | 39.93K | -82.82K | 178.47K | -128.25K | 18.96K | 93.21K |
Cash generated by operating activities | 443.78K | 34.79K | -1.77M | 236.65K | -4.73K | 2.47M | 1.60M | -237.90K | -375.14K | -1.16M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -443.78K | 0 | 0 | -20.75K | -15.31K | -41.83K | -20.33K | 0 | -8.30K | -60.95K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -63.09K | 273.04K | 1.03M | 1.3K | 641 |
Cash generated by investing activities | 0 | 0 | 0 | -20.75K | -15.31K | -104.93K | -11.60K | 300 | -7.00K | -70.31K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 11K | 0 | 0 | 0 | 0 | 655.39K | 190K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -1.94M | 0 | 0 | -40.58K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.64M | -839.14K | 275.05K | -1.93M | 110.00K | -910.51K | 82.75K | 0 |
Cash used in financing activities | -353.47K | -440.13K | 1.14M | -127.74K | 275.05K | -2.33M | -1.56M | 896.92K | 322.75K | 1.29M |
Net Change In Cash | 90.31K | -405.33K | -634.26K | 88.14K | 254.99K | 39.59K | 26.26K | 659.31K | -59.39K | 55.21K |
Cash at end of period | 238.16K | 147.85K | 553.19K | 1.18M | 1.09M | 844.31K | 804.71K | 667.47K | 8.15K | 67.55K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |